Burger line Burger line Burger line
Logo Logo Logo
Burger line Burger line Burger line
Sign in
Sign in

Former Gilead Sciences R&D chief Norbert Bischofberger named CEO of Kronos Bio

Kronos Bio on Wednesday announced the appointment of former Gilead Sciences head of R&D Norbert Bischofberger as its CEO.

The news comes after Bischofberger disclosed in March his intention to leave the drugmaker at the end of last month, having joined the company in 1990.

Bischofberger remarked "the science behind Kronos is compelling," with the company currently advancing two preclinical programmes targeting MYC and the androgen receptor for the treatment of cancer.

May 23rd, 2018


0
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote

We use "cookies*  to ensure the functionality of our website, recognise your browser or device, learn more about your interests, and provide you with essential features and services and for additional purposes, including:

Recognising you when you sign-in to use our services. This allows us to provide you with product recommendations, display personalised content, and provide other customised features and services.
Keeping track of your specified preferences. You may set your preferences through Your Account..
Keeping track of items stored in your shopping basket and personal cabinet.
Conducting research and diagnostics to improve ChemDiv’s content, products, and services.
Delivering content, including ads, relevant to your interests on ChemDiv’s site
Reporting. This allows us to measure and analyse the performance of our services.

By  cookies you give consent to the processing of your personal data, including transfer to third parties. Further information can be found in our privacy policy.

Accept all cookies